Health & Beauty

Up to now, China has provided more than 2.2 billion doses of COVID-19 vaccines to more than 120 countries and international organizations, and has successively transferred technologies to more than 20 countries and cooperated in the production of vaccines, forming an annual production capacity of 1 billion doses of COVID-19 vaccines overseas. China's vaccines span mountains and seas, continue to promote the development of global public health, and jointly build an immune barrier.

"Greatly improve the UAE's biomedical R&D and production capacity and level"

Located in the Khalifa Industrial Zone, 60 kilometers north of the city center of Abu Dhabi, United Arab Emirates, a high-standard vaccine production base co-operated by China and Arab states is in full swing. Pipeline installation is proceeding in an orderly manner.

"Dozens of technical backbones from Sinopharm Group China Biotechnology are working intensively here, actively sharing their experience with the Afghan side in production technology, quality management, biosafety management, etc." said Nasser Yamashi, the project leader of the Afghan side. The base will be operated by Haya Biotechnology Co., Ltd. jointly established by Sinopharm Group China Biotechnology and the UAE G42 Group. "The Chinese team members came to the UAE at the most severe time of the epidemic, overcame harsh conditions such as high temperature and sandstorms, worked hard and performed their duties. It has contributed to the anti-epidemic cooperation between the two countries."

According to reports, after the production base is completed, it will be the largest multi-category vaccine preparation and warehousing and distribution center in the UAE and even the Middle East.

For more than two years, China and the UAE have stood by each other, overcome difficulties together, strengthened anti-epidemic cooperation, and continuously deepened the comprehensive strategic partnership between the two countries. The UAE has become a regional vaccine production, distribution and transportation center, and one of the countries with the highest vaccination rates in the world. Amashi said that the UAE's clinical data show that the Sinopharm's new crown vaccine has good protective efficacy and high safety, providing a solid guarantee for the global fight against the new crown pneumonia epidemic. "The vaccine production base will greatly enhance the UAE's biomedical R&D and production capacity and level. At the same time, with the help of local shipping and logistics advantages, vaccines can also be quickly supplied to North Africa, South America and other regions."

The UAE President Mohammed said that the UAE side is willing to continue to support each other with China, continue to expand areas of cooperation, and protect the lives and health of the people of the two countries.

UAE Ambassador to China Ali Zahiri said that UAE and China have not only cooperated in the production of new crown vaccines, but also carried out all-round cooperation in the field of medicine and health to build mutual trust and friendship. "I believe that with joint efforts, the cooperation between the two sides can bear fruit in more fields and make greater contributions to the lives and health of the people of Afghanistan and China as well as people from all over the world."

"The cost of using vaccines will be greatly reduced in the future"

On the site of the Doboj Hospital project in Bosnia and Herzegovina undertaken by a Chinese company, translator Bozana Bjelic was very busy. "Last year, my relatives and friends were vaccinated with the new crown vaccine produced by China Sinopharm Group for the first time, and now we are all at ease. In Bosnia and Herzegovina, most people choose to get the Chinese vaccine without hesitation."

In August 2021, Bosnia and Herzegovina purchased 500,000 doses of Sinopharm vaccine from China, which is the first batch of new crown vaccine purchased by the federal government of Bosnia and Herzegovina. Bjelic said: "China's vaccines are safe, reliable and easy to store. I have seen from the news that hundreds of thousands of doses of vaccines purchased by our country from other countries cannot be used due to improper storage, which is distressing."

At present, more than 80% of the vaccinated population in Serbia are vaccinated by Chinese vaccines. Serbian virologist Tanja Yovanovic's research results show that after the booster shot, about 90% of the Chinese vaccine recipients have greatly improved antibody levels.

The first Chinese vaccine factory in Europe is under intense construction in Belgrade, the capital of Serbia. After the factory is officially put into operation, the annual production capacity will be about 30 million doses, and 10 million doses of the new crown inactivated vaccine can also be subpackaged, which will meet the needs of Serbia and neighboring countries. Serbian President Vucic said in an interview with the media that with China's timely help, Serbia has effectively promoted the anti-epidemic work and effectively protected the lives, health and safety of its people.

Bijelic is looking forward to the Serbian vaccine factory: "The factory is located in our neighboring country. In the future, the cost of using vaccines will be greatly reduced, and the medical and health conditions of the entire region will also be improved."

"China's support is our guarantee to defeat the epidemic"

Not long ago, in Managua, the capital of Nicaragua, 32-year-old Teresa and her two sons were vaccinated against the new crown vaccine produced in China. "After the vaccination, everyone feels safer to travel. I want to say thank you for the help from China."

In December 2021, Nicaragua received 1 million doses of the new crown vaccine donated by China. Christian Toledo, director of the Nicaragua Health Surveillance Agency, said that at present, the number of new confirmed cases of new coronary pneumonia, hospitalizations and deaths in Nigeria have remained at a low level, "thanks to the health protection provided by the Chinese vaccine for the people of Nigeria. . China provides us with vaccines, which is a great thing to improve people's livelihood in Nicaragua!"

"The advantage of Chinese vaccines is that they can be stored stably for a long time under conventional refrigeration conditions, and are suitable for use in remote areas with incomplete infrastructure or without extremely high refrigeration facilities, which greatly reduces the cost of vaccine distribution and vaccination." Toledo emphasized, For developing countries, "this is a great convenience". Meanwhile, tests have shown that the Chinese vaccine has very high antibody levels.

In mid-May this year, a new batch of 2.5 million doses of Sinovac vaccines assisted by China arrived in Quito, the capital of Ecuador. Liana, a nurse who works at a vaccination site in Quito, vaccinates local residents every day. She said that the Sinovac vaccine and CanSino vaccine from China have good immunization effects and are generally welcomed.

At present, more than 13.9 million Ecuadorians have completed two doses of the new crown vaccine, accounting for about 83% of the target population. The vaccines provided by China account for about 53% of the total vaccines received by Ecuador. Thanks to the high vaccination rate, the epidemic in Ecuador is basically under control, and social and economic life is recovering steadily.

It is reported that China Sinovac has reached an agreement with the relevant departments of many Latin American countries such as Ecuador, Chile, Colombia and Brazil to cooperate with the local authorities to build a vaccine factory to produce a variety of vaccine products including the new crown vaccine. Ecuadorian Health Minister Jimena Garzon said: "If there is no Chinese vaccine, Ecuador's vaccination progress will be greatly reduced. China's support is our guarantee to defeat the epidemic."